Literature DB >> 18039801

Colonization and persistence of antibiotic-resistant Enterobacteriaceae strains in infants nursed in two neonatal intensive care units in East London, United Kingdom.

Michael Millar1, Alex Philpott, Mark Wilks, Angela Whiley, Simon Warwick, Enid Hennessy, Pietro Coen, Stephen Kempley, Fiona Stacey, Kate Costeloe.   

Abstract

Stool samples were collected from infants nursed in two neonatal intensive care units (NICUs) in East London, United Kingdom. The aim of the study was to determine the incidence of and risk factors for the carriage of multiresistant Enterobacteriaceae strains (MRE; resistant to three or more classes of antibiotic) and the extent of the persistence of resistant strains following discharge. Sixty-two (50%) of 124 infants had acquired MRE by 2 weeks of postnatal age, and 69 (56%) infants had acquired MRE by discharge. The proportions of infants at 2 weeks carrying strains that were resistant to antibiotics were the following: tetracycline, 79%; amoxicillin, 78%; cephalosporins, 31%; trimethoprim, 20%; piperacillin-tazobactam, 11%; chloramphenicol, 9%; and aminoglycoside, 4%. A gestational age of less than 26 weeks was a risk factor for colonization with MRE at discharge, but not at 2 weeks. Analysis within a NICU showed that exposure of an infant to a specific antibiotic in the NICU was not a risk factor for the carriage of a strain resistant to that antibiotic. Estimates of persistence from discharge to 6 months were the following: for tetracycline, 57% (95% confidence intervals [CI], 0.35 to 0.87); chloramphenicol, 49% (95% CI, 0.20 to 0.83); trimethoprim, 45% (95% CI, 0.22 to 0.74); piperacillin-tazobactam, 42% (95% CI, 0.20 to 0.71); and augmentin, 34% (95% CI, 0.11 to 0.66). Strains resistant to cephalosporins or aminoglycosides showed lower levels of persistence. Nine of 34 infants (26.5%) with Escherichia coli and 4 (7.1%) of 56 infants with Klebsiella spp. at discharge carried strains indistinguishable by randomly amplified polymorphic DNA and antibiotic susceptibility patterns at 6 months. MRE were found at high frequency in the infants during their stay in the NICU and persisted in a proportion of infants.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18039801      PMCID: PMC2238075          DOI: 10.1128/JCM.00832-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  41 in total

Review 1.  Persistence of antibiotic resistant bacteria.

Authors:  Dan I Andersson
Journal:  Curr Opin Microbiol       Date:  2003-10       Impact factor: 7.934

2.  Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients.

Authors:  Jesús Rodríguez-Baño; Maria Dolores Navarro; Luisa Romero; Luis Martínez-Martínez; Miguel A Muniain; Evelio J Perea; Ramón Pérez-Cano; Alvaro Pascual
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

3.  Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients.

Authors:  R Colodner; W Rock; B Chazan; N Keller; N Guy; W Sakran; R Raz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-02-19       Impact factor: 3.267

4.  Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriaceae in a neonatal intensive care unit.

Authors:  Darren R Linkin; Neil O Fishman; Jean Baldus Patel; Jeffrey D Merrill; Ebbing Lautenbach
Journal:  Infect Control Hosp Epidemiol       Date:  2004-09       Impact factor: 3.254

5.  Pathogen-specific early mortality in very low birth weight infants with late-onset sepsis: a national survey.

Authors:  Imad R Makhoul; Polo Sujov; Tatiana Smolkin; Ayala Lusky; Brian Reichman
Journal:  Clin Infect Dis       Date:  2004-12-17       Impact factor: 9.079

6.  Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997.

Authors:  D J Diekema; M A Pfaller; R N Jones; G V Doern; P L Winokur; A C Gales; H S Sader; K Kugler; M Beach
Journal:  Clin Infect Dis       Date:  1999-09       Impact factor: 9.079

7.  Trimethoprim-resistant Escherichia coli in households of children attending day care centers.

Authors:  M Fornasini; R R Reves; B E Murray; A L Morrow; L K Pickering
Journal:  J Infect Dis       Date:  1992-08       Impact factor: 5.226

8.  Adaptation to the fitness costs of antibiotic resistance in Escherichia coli.

Authors:  S J Schrag; V Perrot; B R Levin
Journal:  Proc Biol Sci       Date:  1997-09-22       Impact factor: 5.349

9.  Prevalence and molecular epidemiology of CTX-M extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals.

Authors:  M Edelstein; M Pimkin; I Palagin; I Edelstein; L Stratchounski
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

10.  Outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit linked to artificial nails.

Authors:  Archana Gupta; Phyllis Della-Latta; Betsy Todd; Pablo San Gabriel; Janet Haas; Fann Wu; David Rubenstein; Lisa Saiman
Journal:  Infect Control Hosp Epidemiol       Date:  2004-03       Impact factor: 3.254

View more
  9 in total

1.  Intestinal carriage of multidrug-resistant gram-negative bacteria in preterm-infants during hospitalization in neonatal intensive care unit (NICU).

Authors:  Polly Soo Xi Yap; Azanna Ahmad Kamar; Chun Wie Chong; Ivan Kok Seng Yap; Kwai Lin Thong; Yao Mun Choo; Mohd Yasim Md Yusof; Cindy Shuan Ju Teh
Journal:  Pathog Glob Health       Date:  2016-09-21       Impact factor: 2.894

2.  In vitro activity of ceftaroline alone and in combination against clinical isolates of resistant gram-negative pathogens, including beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa.

Authors:  Céline Vidaillac; Steve N Leonard; Helio S Sader; Ronald N Jones; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2009-04-06       Impact factor: 5.191

Review 3.  Neonatal sepsis: the gut connection.

Authors:  S Basu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-09-12       Impact factor: 3.267

4.  Meropenem vs standard of care for treatment of late onset sepsis in children of less than 90 days of age: study protocol for a randomised controlled trial.

Authors:  Irja Lutsar; Ursula M T Trafojer; Paul T Heath; Tuuli Metsvaht; Joseph Standing; Susanna Esposito; Vincent Meiffredy de Cabre; Clarissa Oeser; Jean-Pierre Aboulker
Journal:  Trials       Date:  2011-09-30       Impact factor: 2.279

5.  Mode of delivery and other risk factors for Escherichia coli infections in very low birth weight infants.

Authors:  Agnieszka Chmielarczyk; Jadwiga Wójkowska-Mach; Dorota Romaniszyn; Paweł Adamski; Ewa Helwich; Ryszard Lauterbach; Monika Pobiega; Maria Borszewska-Kornacka; Ewa Gulczyńska; Agnieszka Kordek; Piotr B Heczko
Journal:  BMC Pediatr       Date:  2014-10-18       Impact factor: 2.125

6.  Frequency and Susceptibility of Bacteria Caused Urinary Tract Infection in Neonates: Eight-Year Study at Neonatal Division of Bahrami Children's Hospital, Tehran Iran.

Authors:  Peymaneh Alizadeh Taheri; Behdad Navabi; Efat Khatibi
Journal:  Iran J Public Health       Date:  2013-10       Impact factor: 1.429

7.  The Increasing Challenge of Multidrug-Resistant Gram-Negative Bacilli: Results of a 5-Year Active Surveillance Program in a Neonatal Intensive Care Unit.

Authors:  Mario Giuffrè; Daniela M Geraci; Celestino Bonura; Laura Saporito; Giorgio Graziano; Vincenzo Insinga; Aurora Aleo; Davide Vecchio; Caterina Mammina
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

8.  Identification of aminoglycoside and β-lactam resistance genes from within an infant gut functional metagenomic library.

Authors:  Fiona Fouhy; Lesley A Ogilvie; Brian V Jones; R Paul Ross; Anthony C Ryan; Eugene M Dempsey; Gerald F Fitzgerald; Catherine Stanton; Paul D Cotter
Journal:  PLoS One       Date:  2014-09-23       Impact factor: 3.240

9.  Impact of extensive antibiotic treatment on faecal carriage of antibiotic-resistant enterobacteria in children in a low resistance prevalence setting.

Authors:  Per Kristian Knudsen; Petter Brandtzaeg; E Arne Høiby; Jon Bohlin; Ørjan Samuelsen; Martin Steinbakk; Tore G Abrahamsen; Fredrik Müller; Karianne Wiger Gammelsrud
Journal:  PLoS One       Date:  2017-11-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.